{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T19:16:49Z","timestamp":1649186209513},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["SEMERGEN - Medicina de Familia"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.semerg.2011.10.022","type":"journal-article","created":{"date-parts":[[2012,1,29]],"date-time":"2012-01-29T23:51:28Z","timestamp":1327881088000},"page":"226-232","source":"Crossref","is-referenced-by-count":0,"title":["Actualizaci\u00f3n en vacunas. Teor\u00eda, realidades y mitos (II) Actualizaci\u00f3n de calendarios vacunales espa\u00f1oles"],"prefix":"10.1016","volume":"38","author":[{"given":"P.","family":"Mart\u00ednez-Mateo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Bustos-Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Gil-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semerg.2011.10.022_bib0005","unstructured":"Consejo Interterritorial del Sistema Nacional de Salud. Calendario de vacunaciones recomendado (2007). Aprobado por el consejo interterritorial el 10 de octubre de 2007 [consultado Mar 2010]. Disponible en: http:\/\/www.msc.es\/ciudadanos\/proteccionSalud\/infancia\/docs\/c2007.pdf"},{"key":"10.1016\/j.semerg.2011.10.022_bib0010","unstructured":"Comit\u00e9 asesor de vacunas de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda [consultado Mar 2010]. Disponible en: http:\/\/vacunasaep.org\/profesionales\/calendario-vacunas"},{"key":"10.1016\/j.semerg.2011.10.022_bib0015","unstructured":"Estudio REVAL. Impact of community-acquired paediatric rotavirus gastroenteritis on familia life: data from the REVAL study [consultado Mar 2010]. Disponible en: http:\/\/www.biomedcentral.com\/1471-2296\/11\/22"},{"key":"10.1016\/j.semerg.2011.10.022_bib0020","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1086\/516716","article-title":"Costs of Community-Acquired Pediatric Rotavirus Gastroenteritis in 7 European Countries: The Reveal Study","volume":"195","author":"Giaquinto","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.semerg.2011.10.022_bib0025","unstructured":"Comit\u00e9 Asesor de Vacunas de la AEP. Manual de Vacunas en Pediatr\u00eda 2008. 4.a ed. [consultado Mar 2010]. Disponible en: http:\/\/vacunasaep.org\/profesionales\/manual-de-vacunas-2008"},{"key":"10.1016\/j.semerg.2011.10.022_bib0030","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1542\/peds.2009-0466","article-title":"Prevention of Rotavirus Disease: Updated Guidelines for Use of Rotavirus Vaccine","volume":"123","author":"American Academy of Pediatrics","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.semerg.2011.10.022_bib0035","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.3201\/eid1210.060384","article-title":"Human rotavirus G9 and G3 as major cause of diarrhea in hospitalized children, Spain","volume":"12","author":"S\u00e1nchez-Faurquier","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.semerg.2011.10.022_bib0040","unstructured":"Ministerio de Sanidad y Pol\u00edtica Social. Nota informativa por profesionales sanitarios. Detecci\u00f3n de ADN de circovirus porcino tipo I y 2 (PCV-1 y PCV-2) en la vacuna frente a rotavirus RotateqR [consultado Mar 2010]. Disponible en: http:\/\/www.aemps.es\/actividad\/alertas\/usoHumano\/calidad\/2010\/NI_CIRCOVIRUS_rotateq_junio10.htm"},{"key":"10.1016\/j.semerg.2011.10.022_bib0045","unstructured":"Food and Drug Administration. Update on Recommendations for the Use of Rotavirus Vaccines [consultado Mar 2010]. Disponible en: http:\/\/www.fda.gov\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/ucm212140.htm"},{"key":"10.1016\/j.semerg.2011.10.022_bib0050","unstructured":"Documento de consenso de las sociedades cient\u00edficas AEP, AEV, SEIP y SEGHNP [consultado Mar 2010]. Disponible en: http:\/\/www.aeped.es\/sites\/default\/files\/Vac_RV_AEP_AEV_SEIP_SEGHNP_junio-2010.pdf"},{"key":"10.1016\/j.semerg.2011.10.022_bib0055","unstructured":"Ficha t\u00e9cnica de Rotateq\u00ae. EMEA [consultado Mar 2010]. Disponible en: http:\/\/www.ema.europa.eu\/docs\/es_ES\/document_library\/EPAR_Product_Information\/human\/000669\/WC500054185.pdf"},{"key":"10.1016\/j.semerg.2011.10.022_bib0060","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1473-3099(04)00938-7","article-title":"Streptococcus pneumoniae colonisation: the key to pneumococcal disease","volume":"4","author":"Bogaert","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.semerg.2011.10.022_bib0065","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0140-6736(00)04222-7","article-title":"Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children","volume":"357","author":"Hausdorff","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.semerg.2011.10.022_bib0070","doi-asserted-by":"crossref","first-page":"457","DOI":"10.4321\/S1139-76322010000400010","article-title":"Estado de portador de neumococo en ni\u00f1os y su relaci\u00f3n la enfermedad invasiva. \u00bfQu\u00e9 ha cambiado tras la introducci\u00f3n de la vacuna conjugada?","volume":"12","author":"Garc\u00eda-Vera","year":"2010","journal-title":"Rev Pediatr Aten Primaria"},{"key":"10.1016\/j.semerg.2011.10.022_bib0075","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1086\/381686","article-title":"Effect of clonal and serotypespecific properties on the invasive capacity of streptococcus pneumonia","volume":"189","author":"Sandgern","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.semerg.2011.10.022_bib0080","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1473-3099(05)01280-6","article-title":"Epidemiological differences among pneumococcal serotypes","volume":"5","author":"Hausdorff","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.semerg.2011.10.022_bib0085","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1086\/313608","article-title":"Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I","volume":"30","author":"Hausdorff","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.semerg.2011.10.022_bib0090","unstructured":"Ministerio de Sanidad y Consumo. Instituto de Salud Carlos III. Enfermedad invasiva por Streptococcus pneumoniae: Implicaci\u00f3n de la vacuna conjugada heptavalente. Abril 2006 [consultado Abr 2010]. Disponible en: http:\/\/www.msc.es\/ciudadanos\/proteccionSalud\/infancia\/docs\/neumo.pdf"},{"key":"10.1016\/j.semerg.2011.10.022_bib0095","series-title":"Expert Committee on biological Standardization. Replacement of: TRS 927. Annex 2. Pneumococcal conjugate vaccines. Recommendations for production and control of pneumococcal conjugate vaccines","year":"2009"},{"key":"10.1016\/j.semerg.2011.10.022_bib0100","unstructured":"Informe del Comit\u00e9 de Expertos Asesor de Vacunas de la Comunidad de Madrid. Sobre la transici\u00f3n de la vacunaci\u00f3n antineumoc\u00f3cica infantil. Madrid: Comit\u00e9 de Expertos Asesor de Vacunas: 2010."},{"key":"10.1016\/j.semerg.2011.10.022_bib0105","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jcv.2004.12.008","article-title":"The epidemiology of human papillomavirus infections","volume":"32","author":"Baseman","year":"2005","journal-title":"J Clin Virol"},{"key":"10.1016\/j.semerg.2011.10.022_bib0110","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1006\/scbi.1999.0146","article-title":"The serological response to papilloma viruses","volume":"9","author":"Dillner","year":"1999","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.semerg.2011.10.022_bib0115","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.semerg.2011.10.022_bib0120","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.1016\/j.vaccine.2006.04.068","article-title":"Inmunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16 and 18","volume":"24","author":"Villa","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.semerg.2011.10.022_bib0125","unstructured":"Grupo de trabajo para la actualizaci\u00f3n del cap\u00edtulo sobre vacuna de t\u00e9tanos y difteria del documento Vacunaci\u00f3n en adultos\u2019. Vacunaci\u00f3n en adultos. Recomendaciones. Vacuna difteria y t\u00e9tanos. Actualizaci\u00f3n 2009. Documento Aprobado por la Comisi\u00f3n de Salud P\u00fablica del Ministerio de Sanidad y Consumo, con fecha: 18 de febrero de 2009 [consultado Abr 2010]. Disponible en: http:\/\/www.mspsi.es\/ciudadanos\/proteccionSalud\/vacunaciones\/docs\/TetanosDifteria_2009.pdf"},{"key":"10.1016\/j.semerg.2011.10.022_bib0130","unstructured":"Comit\u00e9 de Expertos Asesor de Vacunas de la Comunidad de Madrid. Informaci\u00f3n t\u00e9cnica. Salud p\u00fablica [consultado Abr 2010]. Disponible en: http:\/\/www.madrid.org\/"}],"container-title":["SEMERGEN - Medicina de Familia"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359311004503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359311004503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T20:26:42Z","timestamp":1543264002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1138359311004503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S1138359311004503"],"URL":"https:\/\/doi.org\/10.1016\/j.semerg.2011.10.022","relation":{},"ISSN":["1138-3593"],"issn-type":[{"value":"1138-3593","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}